Clinical trial
Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters
NCT05383274 is registered in ClinicalTrials.gov with Urotronic Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters
- Lead sponsor
- Urotronic Inc.
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- February 14, 2022
- Completion date
- December 30, 2027
- Enrollment
- 34 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.